Economic Evaluation of Drug Abuse Prevention with Rural African AmericanYouth

Information

  • Research Project
  • 7582458
  • ApplicationId
    7582458
  • Core Project Number
    R01DA024644
  • Full Project Number
    1R01DA024644-01A1
  • Serial Number
    24644
  • FOA Number
    PA-07-22
  • Sub Project Id
  • Project Start Date
    9/15/2008 - 15 years ago
  • Project End Date
    6/30/2013 - 11 years ago
  • Program Officer Name
    SIMS, BELINDA E.
  • Budget Start Date
    9/15/2008 - 15 years ago
  • Budget End Date
    6/30/2009 - 15 years ago
  • Fiscal Year
    2008
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    9/11/2008 - 15 years ago

Economic Evaluation of Drug Abuse Prevention with Rural African AmericanYouth

[unreadable] DESCRIPTION (provided by applicant): Adolescent drug abuse poses a major threat to the health and well-being of youth, forecasting poor psychological and social adjustment, involvement with the criminal justice system, transmission of HIV/AIDS and other sexually transmitted infections, and future drug abuse problems. Despite the fact that the potential benefits of preventing adolescent drug abuse are enormous, very little is known about the implementation costs and economic impact of drug abuse prevention programs. Policymakers, community-based organizations, school systems, health departments, and other agencies that deliver drug abuse prevention services need this information to make difficult decisions regarding the allocation of scarce public health resources. For the several million African American families with adolescents living in rural, resource-poor environments, no data exist on the costs and benefits of preventing drug abuse. To address this need, Dr. Corso has partnered with Drs. Brody and Kogan, who are conducting a prevention trial of a drug abuse prevention program for rural African American adolescents, and with Dr. E. Michael Foster, who has extensive experience in conducting economic evaluations of youth-focused prevention programs. In this application, we request funding to conduct an economic evaluation of the Strong African American Families-Teen (SAAF-T) program. A developmentally appropriate adaptation of the efficacious SAAF drug abuse prevention program for elementary school youth, SAAF-T is based on 15 years of longitudinal research with rural African American families and extensive community input. It is currently being tested in a randomized prevention trial with 500 10th-grade students and their families. Three complementary economic analyses, which provide a comprehensive assessment of SAAF-T's economic impact, are proposed: programmatic cost analysis, benefit-cost analysis, and cost-effectiveness analysis. The SAAF-T prevention trial provides an invaluable opportunity both to determine the costs and benefits of the intervention on an underserved and understudied population and to adapt methods from the economic evaluation and drug abuse treatment literature that will foster future research and policy development on drug abuse prevention. PUBLIC HEALTH RELEVANCE: A multi-disciplinary team of experts in economic evaluation and drug abuse prevention propose to conduct a prospective economic evaluation of a family-centered drug abuse prevention program designed for rural African American adolescents. The proposed economic analyses provide important information for policy makers and drug abuse prevention providers regarding the costs and the benefits of drug abuse prevention. The proposed study would support future efforts to disseminate effective drug abuse programs to the several million African American youth living in resource poor, rural environments. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE ON DRUG ABUSE
  • Activity
    R01
  • Administering IC
    DA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    325996
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    279
  • Ed Inst. Type
    SCHOOLS OF PUBLIC HEALTH
  • Funding ICs
    NIDA:325996\
  • Funding Mechanism
  • Study Section
    NIDA
  • Study Section Name
    Neuropharmacology Research Subcommittee
  • Organization Name
    UNIVERSITY OF GEORGIA (UGA)
  • Organization Department
    PUBLIC HEALTH &PREV MEDICINE
  • Organization DUNS
  • Organization City
    ATHENS
  • Organization State
    GA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    306027411
  • Organization District
    UNITED STATES